A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...

Flu virus that can lead to paralysis and brain swelling detected in California’s wastewater - This comes on the heels of one ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

The highest risk of transmission of SARS-CoV-2 was in the first 72 hours at room temperature and first 24 hours at 37℃.

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

Basilica of St. Andrews holds vespers before Pope Francis’ funeral FILE - This electron microscope image provided by the National Institutes of Health shows human respiratory syncytial virus ...

A Department of Health and Human Services spokesperson has ... People 50 to 59 should be able to get vaccinated against respiratory syncytial virus have risks including heart disease, diabetes ...